BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/08/2014

FDA Clears Levoleucovorin Calcium for Approval

The FDA has determined that FUSILEV (levoleucovorin calcium) injection, 175 mg/17.5 mL and 250 mg/25 mL, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →